Rite Aid Corporation (RAD) Credit Suisse 31st Annual Healthcare Conference Call November 9, 0000 4:25 PM ET
Company Participants
Heyward Donigan - CEO
Matt Schroeder - CFO
Conference Call Participants
Albert Rice - Credit Suisse
Albert Rice
Hi, everyone. I'm A.J. Rice, the Health Care Services Analyst at Credit Suisse. And we're very happy to have up next in our presentation, I'll do a fireside chat with Heyward Donigan, the Chief Executive Officer; and Matt Schroeder, the Chief Financial Officer at Rite Aid. Thank you guys for participating again this year.
Question-and-Answer Session
Q - Albert Rice
Maybe just might be helpful just to get a broad update on the company's broad strategy. I'm sure there are people in the room and on the webcast that probably haven't looked at Rite Aid in a while and are looking for a refresher. So maybe I'll just give you an open-end question like that, if that's okay?
Heyward Donigan
Of course. Thank you. Thanks for the opportunity. A lot of people forgot our original strategy because COVID rounded out. And so just as a reminder, I've been with the company for 3 years. And we had our first Analyst Day in 20 years back in the beginning of 2020, literally a day before the whole country got shut down. And so we are excited to get back to business with COVID as opposed to getting back to business without COVID. It's more of a living with COVID thing.
But just a reminder, we're a pharmacy services company. We are doubling down in the pharmacy business. It's a $1 trillion marketplace. And just a reminder of the assets that we have to participate in that $1 trillion market. We have a mail order pharmacy, a specialty pharmacy, a company called Health Dialog. We have Laker adjudication platform, which is a platform for Pharmacy Benefit
- Read more current RADCQ analysis and news
- View all earnings call transcripts